Platelet to lymphocyte ratio correlates with diabetic foot risk and foot ulcer in patients with type 2 diabetes.

Diabetic foot ulcer is a major complication in patients with diabetes. Platelet-lymphocyte ratio (PLR) has been reported to have a predictive effect to some diabetic complications in recent years. However, it has not been fully elucidated about the relationship between diabetic foot risk or diabetic foot ulcer and PLR in patients with type 2 diabetes. Therefore, we aimed to evaluate this relationship. In this cross-sectional study, we evaluated the relationships between patient's diabetic foot risk with the criteria of the International Working Group on the Diabetic Foot (IWGDF) and prevalent foot ulcer, and PLR in 453 consecutive patients with type 2 diabetes. Propensity score analysis was used to adjust the difference of covariates; age, sex, duration of diabetes, body mass index (BMI), HbA1c, current smoking, hypertension, dyslipidemia, neuropathy, PAD, foot deformity and history of foot ulcers. PLR was higher in patients with high risk diabetic foot or foot ulcer (117 ± 40 vs. 107 ± 31, p = 0.003 and 148 ± 65 vs. 113 ± 56, p < 0.001). A receiver-operating characteristic curve demonstrated that PLR of 130.6 constitutes the cut-off value for prevalent foot ulcer with sensitivity 0.85 and specificity 0.70. Multivariate logistic regression analysis revealed that PLR was positively correlated with prevalent foot ulcer (odds ratio, 1.02; 95% confidence interval 1.01-1.04, p = 0.003) after adjusted for several variables with propensity score analysis. Our results demonstrated that PLR can be a marker for high risk diabetic foot and diabetic foot ulcer in patients with type 2 diabetes.

[1]  Yue Yin,et al.  Association between neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and diabetic retinopathy among diabetic patients without a related family history , 2020, Diabetology & Metabolic Syndrome.

[2]  Marc P. Bonaca,et al.  SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials , 2019, The Lancet.

[3]  O. Tomonaga,et al.  Declining trends of diabetic nephropathy, retinopathy and neuropathy with improving diabetes care indicators in Japanese patients with type 2 and type 1 diabetes (JDDM 46) , 2018, BMJ Open Diabetes Research & Care.

[4]  T. Kitazono,et al.  Incidence of diabetic foot ulcer in Japanese patients with type 2 diabetes mellitus: The Fukuoka diabetes registry. , 2018, Diabetes research and clinical practice.

[5]  N. Nakamura,et al.  Relationship between limited joint mobility of the hand and diabetic foot risk in patients with type 2 diabetes , 2017, Journal of diabetes.

[6]  F. Bowling,et al.  The diabetic foot in 2015: an overview , 2016, Diabetes/metabolism research and reviews.

[7]  J. Reekers,et al.  IWGDF guidance on the diagnosis, prognosis and management of peripheral artery disease in patients with foot ulcers in diabetes , 2016, Diabetes/metabolism research and reviews.

[8]  Benjamin A Lipsky,et al.  IWGDF guidance on the diagnosis and management of foot infections in persons with diabetes , 2016, Diabetes/metabolism research and reviews.

[9]  Benjamin A Lipsky,et al.  The 2015 IWGDF guidance documents on prevention and management of foot problems in diabetes: development of an evidence‐based global consensus , 2016, Diabetes/metabolism research and reviews.

[10]  A. Gurel,et al.  Association of hematological indicies with diabetes, impaired glucose regulation and microvascular complications of diabetes. , 2015, International journal of clinical and experimental medicine.

[11]  Dario Pitocco,et al.  Platelet mean volume, distribution width, and count in type 2 diabetes, impaired fasting glucose, and metabolic syndrome: a meta‐analysis , 2015, Diabetes/metabolism research and reviews.

[12]  M. Pan,et al.  Insufficient early detection of peripheral neurovasculopathy and associated factors in rural diabetes residents of Taiwan: a cross-sectional study , 2014, BMC Endocrine Disorders.

[13]  H. Eker,et al.  Investigation of mean platelet volume in patients with type 2 diabetes mellitus and in subjects with impaired fasting glucose: a cost-effective tool in primary health care? , 2014, International journal of clinical and experimental medicine.

[14]  K. Turkmen,et al.  Association of epicardial adipose tissue, neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio with diabetic nephropathy. , 2014, International journal of clinical and experimental medicine.

[15]  I. Sari,et al.  Neutrophil to lymphocyte and platelet to lymphocyte ratio in patients with dipper versus non-dipper hypertension , 2014, Clinical and experimental hypertension.

[16]  A. Gerger,et al.  Platelet-to-Lymphocyte Ratio: A Novel Marker for Critical Limb Ischemia in Peripheral Arterial Occlusive Disease Patients , 2013, PloS one.

[17]  K. Turkmen,et al.  Platelet‐to‐lymphocyte ratio better predicts inflammation than neutrophil‐to‐lymphocyte ratio in end‐stage renal disease patients , 2013, Hemodialysis international. International Symposium on Home Hemodialysis.

[18]  Dorit Tzur,et al.  White Blood Cells Count and Incidence of Type 2 Diabetes in Young Men , 2013, Diabetes Care.

[19]  Prof. Dr. Asher. Fawwad,et al.  Role of platelet indices, glycemic control and hs-CRP in pathogenesis of vascular complications in type-2 diabetic patients , 2012, Pakistan journal of medical sciences.

[20]  S. Tangjitgamol,et al.  Platelet to lymphocyte ratio as a prognostic factor for epithelial ovarian cancer , 2012, Journal of gynecologic oncology.

[21]  K. Alexiadou,et al.  Management of Diabetic Foot Ulcers , 2012, Diabetes Therapy.

[22]  N. Nakamura,et al.  Relationship between cardio-ankle vascular index (CAVI) and coronary artery calcification (CAC) in patients with type 2 diabetes mellitus , 2012, Heart and Vessels.

[23]  H. ten Cate,et al.  The hemostatic system as a modulator of atherosclerosis. , 2011, The New England journal of medicine.

[24]  R. Agha,et al.  Neutrophil-Lymphocyte Ratio Predicts Medium-Term Survival Following Elective Major Vascular Surgery: A Cross-Sectional Study , 2011, Vascular and endovascular surgery.

[25]  A. Adler,et al.  Association between glycated haemoglobin and the risk of lower extremity amputation in patients with diabetes mellitus—review and meta-analysis , 2010, Diabetologia.

[26]  Yasuhiko Tomino,et al.  Revised equations for estimated GFR from serum creatinine in Japan. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[27]  Michael J. Mueller,et al.  Comprehensive Foot Examination and Risk Assessment , 2008, Diabetes Care.

[28]  D. Margolis,et al.  Association Between Renal Failure and Foot Ulcer or Lower-Extremity Amputation in Patients With Diabetes , 2008, Diabetes Care.

[29]  L. Lavery,et al.  What are the most effective interventions in preventing diabetic foot ulcers? , 2008, International wound journal.

[30]  W. Houtum,et al.  Practical guidelines on the management and prevention of the diabetic foot , 2008, Diabetes/metabolism research and reviews.

[31]  M. Gawaz,et al.  Platelet-vessel wall interactions in atherosclerotic disease , 2008, Thrombosis and Haemostasis.

[32]  A. Kashiwagi,et al.  Rationale and usefulness of newly devised abbreviated diagnostic criteria and staging for diabetic polyneuropathy. , 2007, Diabetes research and clinical practice.

[33]  T Fahey,et al.  Predicting foot ulcers in patients with diabetes: a systematic review and meta-analysis. , 2006, QJM : monthly journal of the Association of Physicians.

[34]  S. Fukumoto,et al.  Platelet activation is associated with hypoadiponectinemia and carotid atherosclerosis. , 2006, Atherosclerosis.

[35]  Patrick J. Heagerty,et al.  Prediction of Diabetic Foot Ulcer Occurrence Using Commonly Available Clinical Information , 2006, Diabetes Care.

[36]  D. Armstrong,et al.  Preventing foot ulcers in patients with diabetes. , 2005, JAMA.

[37]  P. Sorlie,et al.  Prevalence of lower-extremity disease in the US adult population >=40 years of age with and without diabetes: 1999-2000 national health and nutrition examination survey. , 2004, Diabetes care.

[38]  S. Fukumoto,et al.  Platelet P-Selectin Expression Is Associated With Atherosclerotic Wall Thickness in Carotid Artery in Humans , 2003 .

[39]  Christian Weyer,et al.  High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes. , 2002, Diabetes.

[40]  D. Armstrong,et al.  Screening techniques to identify people at high risk for diabetic foot ulceration: a prospective multicenter trial. , 2000, Diabetes care.

[41]  E H Wagner,et al.  Incidence, outcomes, and cost of foot ulcers in patients with diabetes. , 1999, Diabetes care.

[42]  A. Boulton,et al.  Multicenter Study of the Incidence of and Predictive Risk Factors for Diabetic Neuropathic Foot Ulceration , 1998, Diabetes Care.

[43]  D. Armstrong,et al.  Practical criteria for screening patients at high risk for diabetic foot ulceration. , 1998, Archives of internal medicine.

[44]  D. Armstrong,et al.  A Supplement to : Foot & Ankle Surgery , 2006 .

[45]  D G Smith,et al.  Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. , 1999, Diabetes care.